NASDAQ:ARAY
Accuray Incorporated Stock News
$2.20
-0.0200 (-0.90%)
At Close: Apr 24, 2024
Baxter (BAX) Q3 Earnings Meet Estimates, Hilrom Adds $735 M
04:32pm, Thursday, 27'th Oct 2022 Zacks Investment Research
Baxter's (BAX) third-quarter results reflect the robust performance of the Medication Delivery business unit and Hilrom's businesses.
Integra's (IART) Q3 Earnings Top, Gross Margin Declines
03:51pm, Thursday, 27'th Oct 2022 Zacks Investment Research
Integra (IART) notices recovery in procedure volumes leading to solid growth across most of its product portfolio in Q3.
Align Technology (ALGN) Q3 Earnings Lag Estimates, Margins Drop
03:45pm, Thursday, 27'th Oct 2022 Zacks Investment Research
The volatility surrounding inflationary pressure, weaker consumer confidence and the lingering impacts of COVID-19 shutdowns continue to pose challenges for Align Technology (ALGN).
CONMED (CNMD) Down on In-Line Q3 Earnings & Lower 2022 View
03:11pm, Thursday, 27'th Oct 2022 Zacks Investment Research
CONMED's (CNMD) adjusted third-quarter earnings reflect strong segmental performance. Unfavorable currency movement hurt sales growth. Inflationary or supply chain challenges hurt gross margin.
Thermo Fisher (TMO) Q3 Earnings Top Estimates, Margins Down
03:43pm, Wednesday, 26'th Oct 2022 Zacks Investment Research
Robust demand for Thermo Fisher's (TMO) laboratory products and biopharma services buoys optimism. However, lower Life Sciences Solutions segment revenues in the third quarter disappoint.
Philips' (PHG) Q3 Earnings Down on Supply Chain Constraints
03:46pm, Tuesday, 25'th Oct 2022 Zacks Investment Research
Koninklijke Philips' (PHG) Q3 top and bottom-line results reflect the negative impact of supply chain constraints, COVID lockdowns in China and the Russia-Ukraine war.
Accuray's (ARAY) New Treatment Package to Boost Patient Outcome
01:53pm, Friday, 14'th Oct 2022 Zacks Investment Research
Accuray's (ARAY) latest automated breast cancer treatment package for the Radixact System is expected to extend and improve the quality of patients' lives.
3 Reasons to Hold Accuray (ARAY) Stock in Your Portfolio
03:48pm, Wednesday, 28'th Sep 2022 Zacks Investment Research
Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.
3 Reasons to Hold Accuray (ARAY) Stock in Your Portfolio
01:33pm, Wednesday, 28'th Sep 2022
Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.
Accuray's (ARAY) Latest Collaboration to Improve Patient Care
04:44pm, Thursday, 08'th Sep 2022 Zacks Investment Research
Accuray (ARAY) partners with Genolier Innovation Hub to unite companies from the MedTech, pharma and biosciences sectors with physicians and scientists for better patient outcomes.
Accuray's (ARAY) Latest Collaboration to Improve Patient Care
02:18pm, Thursday, 08'th Sep 2022
Accuray (ARAY) partners with Genolier Innovation Hub to unite companies from the MedTech, pharma and biosciences sectors with physicians and scientists for better patient outcomes.
Are Options Traders Betting on a Big Move in Accuray (ARAY) Stock?
11:44am, Friday, 19'th Aug 2022 Zacks Investment Research
Investors need to pay close attention to Accuray (ARAY) stock based on the movements in the options market lately.
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
08:20am, Friday, 12'th Aug 2022 Benzinga
Gainers
Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.
TOP Financial Group Limited (
Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday's Mid-Day Session
05:49pm, Thursday, 11'th Aug 2022 Benzinga
Gainers
Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering.
T2 Biosystems, Inc. (NASDAQ: TTOO) s
Accuray (ARAY) Q4 Earnings Beat Estimates, Margins Down
05:13pm, Thursday, 11'th Aug 2022 Zacks Investment Research
Despite solid Product revenues, Accuray (ARAY) reports an overall soft Q4 performance.
